Account Executive at BillionToOne

Dunellen, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Biotechnology, DiagnosticsIndustries

Requirements

Outstanding prenatal sales executive experience
Experience in diagnostic/genetic testing product sales

Responsibilities

Increasing utilization of UNITY Fetal Risk Screen and driving market demand
Delivering clinical information to OBGYN clinics and MFMs practices
Communicating the value proposition of the test to physicians and patients
Influencing the evolution of the test to better serve market needs

Skills

Key technologies and capabilities for this role

Diagnostic SalesGenetic Testing SalesPrenatal SalesNIPTOBGYN OutreachMFM SalesField SalesPhysician EducationTerritory ManagementClinical Communication

Questions & Answers

Common questions about this position

What is the salary for the Prenatal Account Executive position?

This information is not specified in the job description.

Is this a remote position or does it require travel?

This is a field sales position requiring work throughout the NJ North territory, reporting to a Regional Manager - Prenatal.

What experience is required for this Account Executive role?

The role requires experience in diagnostic/genetic testing product sales as an outstanding prenatal sales executive.

What is the company culture like at BillionToOne?

BillionToOne maintains a unique culture that is diverse, passionate, and innovative despite substantial growth, and has been recognized by Forbes as one of America's Best Startup Employers for 2024.

What makes a strong candidate for this Prenatal Account Executive position?

A strong candidate is an outstanding prenatal sales executive with experience in diagnostic/genetic testing product sales, capable of driving market demand for the UNITY Fetal Risk Screen in OBGYN clinics and MFM practices.

BillionToOne

Molecular diagnostics for prenatal and oncology testing

About BillionToOne

BillionToOne specializes in molecular diagnostics within the healthcare sector, focusing on prenatal screening and oncology testing. Their proprietary QCT technology allows for the detection and quantification of diseases at a single base-pair resolution, enabling the identification of minute variations in DNA. The company offers two main products: Northstar Select™, which helps determine the best initial therapy for patients, and Northstar Response™, which tracks the effectiveness of that therapy. Unlike many competitors, BillionToOne emphasizes accuracy, efficiency, and accessibility in molecular testing, providing diagnostic services directly to healthcare providers. Their goal is to positively impact healthcare by making molecular testing more reliable and available to everyone.

Menlo Park, CaliforniaHeadquarters

2016Year Founded

$380.2MTotal Funding

SERIES_DCompany Stage

Biotechnology, HealthcareIndustries

201-500Employees

Benefits

Competitive pay

Retirement savings package

Parental leave

Free snacks & lunches

Medical, dental, & vision premiums

On campus perks

Free-on-site EV charging

Risks

Emerging biotech startups could threaten BillionToOne's market share.

Rapid technological advancements may render their current technology obsolete.

Expansion into new facilities may face operational challenges or delays.

Differentiation

BillionToOne's QCT technology detects DNA variations at single base-pair resolution.

Their UNITY Fetal Antigen NIPT is the first US cfDNA test for fetal antigen genotyping.

They replace invasive amniocentesis with a safe, affordable blood test for prenatal screening.

Upsides

BillionToOne achieved a billion-dollar valuation with a $130 million funding round.

Their new Austin facility will create 1,000 jobs, boosting production and local economy.

Recognition as Diagnostics Company of the Year highlights their industry leadership.

Land your dream remote job 3x faster with AI

Try Jobo Free